Work

Data from Chemoprevention Meets Glucose Control

Year: 2023

Type: other

Abstract: The report by Memmott et al. (beginning on page 1066 in this issue of the journal) assessing the efficacy of the antidiabetes drug metformin in a mouse model of lung carcinogenesis suggests protective effects via two possible avenues: Decreased circulating insulin and insulin-like growth factor levels and energy stress leading to inhibition of mammalian target of rapamycin signaling. These potential mechanisms are discussed in this perspective, as are their implications for cancer prevention and therapy. Cancer Prev Res; 3(9); 1049–52. ©2010 AACR.

DOI: 10.1158/1940-6207.c.6544083.v1

Authors: Jeffrey A. Engelman, Lewis C. Cantley

Language: English

Topic: Metabolism, Diabetes, and Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4392701088

Cites:

Cited by:

Related to: 10